bromocriptine has been researched along with Diabetes Mellitus, Type 1 in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (46.15) | 18.7374 |
1990's | 4 (30.77) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (7.69) | 24.3611 |
2020's | 2 (15.38) | 2.80 |
Authors | Studies |
---|---|
Baumgartner, AD; Gross, S; Lyon, E; Nadeau, KJ; Polsky, S; Schafer, M; Schauer, IE; Snell-Bergeon, JK; Tell, SS; Vigers, T | 1 |
Bloomgarden, Z | 1 |
Garg, SK; Michels, AW; Shah, VN | 1 |
Alexander, H; Herter, U; Ulrich, FE | 2 |
Blickle, JF; De Laharpe, F; Schlienger, JL; Stephan, F | 1 |
Christensen, NC; Hagen, C; Nielsen, MD; Petersen, S | 1 |
Dunbar, JC; Gala, RR; Hawkins, TA | 1 |
Alves, V; Coulaud, J; Dardenne, M; Durant, S; El Hasnaoui, A; Homo-Delarche, F | 1 |
Neidhart, M | 1 |
Cassar, J; Edwards, R; Kohner, EM; Mashiter, K | 1 |
Atkison, PR; Dupre, J; Jenner, MR; Mahon, JL; Momah, CI; Paul, TL; Stiller, CR | 1 |
Raymond, CA | 1 |
1 review(s) available for bromocriptine and Diabetes Mellitus, Type 1
Article | Year |
---|---|
Use of non-insulin therapies for type 1 diabetes.
Topics: Allylamine; Animals; Blood Glucose; Bromocriptine; Cardiovascular Diseases; Colesevelam Hydrochloride; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Dipeptidyl-Peptidase IV Inhibitors; Gastrins; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Islet Amyloid Polypeptide; Leptin; Metformin; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Sulfonylurea Compounds; Thiazolidinediones; United States | 2013 |
2 trial(s) available for bromocriptine and Diabetes Mellitus, Type 1
Article | Year |
---|---|
Bromocriptine quick-release as adjunct therapy in youth and adults with type 1 diabetes: A randomized, placebo-controlled crossover study.
Topics: Adolescent; Adult; Blood Glucose; Blood Glucose Self-Monitoring; Bromocriptine; Child; Creatinine; Cross-Over Studies; Diabetes Mellitus, Type 1; Double-Blind Method; Glucagon-Like Peptide 1; Humans; Hyperglycemia; Insulin; Insulin Resistance; Lipids; Middle Aged; Young Adult | 2022 |
Interaction of bromocriptine and cyclosporine in insulin dependent diabetes mellitus: results from the Canadian open study.
Topics: Blood Glucose; Bromocriptine; C-Peptide; Creatine; Cyclosporins; Diabetes Mellitus, Type 1; Drug Synergism; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Pilot Projects | 1990 |
10 other study(ies) available for bromocriptine and Diabetes Mellitus, Type 1
Article | Year |
---|---|
Various and sundry recent publications.
Topics: Bromocriptine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Heart Rate; Humans; Insulin Resistance; Obesity | 2021 |
[Carbohydrate metabolism in normo- and hyperprolactinemic sterility patients and the possible treatment of sterility in juvenile diabetes mellitus with bromocriptine (Parlodel-Sandoz)].
Topics: Adult; Blood Glucose; Bromocriptine; Diabetes Mellitus, Type 1; Female; Humans; Infertility, Female; Prolactin | 1981 |
[Carbohydrate metabolism in normo- and hyperprolactinemic sterile patients and the possible treatment of sterility in juvenile diabetes mellitus with bromocriptine (Parlodel-Sandoz)].
Topics: Adult; Blood Glucose; Bromocriptine; Carbohydrate Metabolism; Diabetes Mellitus, Type 1; Female; Humans; Hyperprolactinemia; Infertility, Female; Prolactin | 1981 |
[Bromocriptine and the growth hormone response to thyroliberin in the insulin-dependent diabetic].
Topics: Adolescent; Adult; Bromocriptine; Diabetes Mellitus, Type 1; Growth Hormone; Humans; Male; Middle Aged; Thyrotropin-Releasing Hormone | 1984 |
Hypernatraemia, diabetes mellitus, hyperprolactinaemia, retarded growth and delayed puberty in a 14 year old girl. Effect of bromocriptine treatment.
Topics: Adolescent; Bromocriptine; Diabetes Mellitus, Type 1; Estradiol; Female; Gonadotropins, Pituitary; Growth Disorders; Humans; Hydrocortisone; Hyperlipidemias; Hypernatremia; Pituitary Function Tests; Prolactin; Puberty, Delayed; Renin | 1981 |
Prolactin modulates the incidence of diabetes in male and female NOD mice.
Topics: Animals; Blood Glucose; Bromocriptine; Diabetes Mellitus, Type 1; Female; Male; Mice; Mice, Inbred NOD; Pituitary Gland, Anterior; Prolactin; Sex Factors | 1994 |
Attempts to pharmacologically modulate prolactin levels and type 1 autoimmune diabetes in the non-obese diabetic (NOD) mouse.
Topics: Animals; Blood Glucose; Bromocriptine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dopamine Agonists; Dopamine Antagonists; Female; Islets of Langerhans; Male; Metoclopramide; Mice; Mice, Inbred NOD; Prolactin; Treatment Outcome | 1995 |
Synergism between long-acting bromocryptine microcapsules and cyclosporine A in the prevention of various autoimmune diseases in rats.
Topics: Animals; Arthritis, Experimental; Autoimmune Diseases; Bromocriptine; Cyclosporine; Delayed-Action Preparations; Diabetes Mellitus, Type 1; Drug Synergism; Female; Male; Ornithine Decarboxylase; Polyarteritis Nodosa; Rats; Rats, Inbred BB; Rats, Inbred Lew; Rats, Sprague-Dawley; Thymus Gland; Uveitis | 1996 |
Letter: Bromocritine and serum-growth-hormone levels in diabetes mellitus.
Topics: Adult; Bromocriptine; Diabetes Mellitus, Type 1; Ergolines; Growth Hormone; Humans; Male; Physical Exertion; Rest | 1975 |
Cyclosporine, in combination with other drugs, studied in insulin-dependent diabetes therapy.
Topics: Bromocriptine; C-Peptide; Cyclosporins; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Humans | 1988 |